LimeLight of The week is

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP)

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

Investment Considerations

• Revenue-generating biosciences company focused on improving the delivery of bioactive compounds through gourmet foods
• Proprietary technology shown to enhance the bioavailability of orally ingested cannabinoids while improving the taste
• Actively developing and selling hemp oil-based gourmet food products through consumer brands ViPova™ and Lexaria Energy

Receive Text Alerts from CannabisNewsWire

Text "Cannabis" to 21000

About CannabisNewsWire (CNW)

CannabisNewsWire (CNW) is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging a professional team of journalists and writers, CNW introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network of over 5,000 key distribution outlets. Cutting through information overload, CNW's innovative and proprietary systems clearly and succinctly deliver its clients much needed visibility, recognition and brand awareness. CNW is where news, content and information converge.